Pharmaceutical Continuous Manufacturing Market Growth Projection: Expected to Surpass $4.58 Billion by 2030 at 11.4% CAGR
Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical continuous manufacturing market from 2026–2035 with trusted insights from The Business Research Company
Across 2026–2030, what is the expected market valuation path of the Pharmaceutical Continuous Manufacturing Market?
The pharmaceutical continuous manufacturing market size has experienced significant expansion recently. It is projected to increase from $2.69 billion in 2025 to $2.97 billion in 2026, progressing at a compound annual growth rate (CAGR) of 10.4%. This historical growth has been driven by factors such as a rise in drug demand volumes, the necessity for improved production efficiency, considerable variability in batch manufacturing, escalating cost pressures on pharmaceutical companies, and initial regulatory pilot approvals.
The pharmaceutical continuous manufacturing market is expected to experience rapid expansion in the coming years. It is projected to grow to $4.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.4%. The growth during this forecast period can be attributed to factors such as the increasing adoption of pcm by large pharmaceutical companies, rising investments in smart factories, the demand for quicker scale-up and commercialization, a focus on supply chain resilience, and advancements in continuous processing equipment. Significant trends anticipated for the forecast period include a shift from batch to end-to-end continuous production, heightened adoption of modular and flexible manufacturing lines, an increasing focus on real-time quality assurance and control, the expansion of continuous manufacturing for API production, and growing regulatory support for continuous manufacturing.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12123&type=smp
Which Drivers Are Supporting The Rise Of The Pharmaceutical Continuous Manufacturing Market?
The future expansion of the pharmaceutical continuous manufacturing market is expected to be propelled by the increasing adoption of industrial automation. Industrial automation refers to the utilization of control systems, such as computers or robots, to manage various industrial processes and machinery, thereby replacing or augmenting human intervention. This automation assists pharmaceutical continuous manufacturing by enabling monitoring and real-time feedback control within CM processes to minimize human error and ensure consistent product quality. For example, in September 2023, data from the World Robotics report, published by the International Federation of Robotics, a Germany-based professional non-profit organization, showed 553,052 industrial robot installations in factories worldwide, reflecting a 5% year-on-year growth rate in 2022. Therefore, the rise in industrial automation is a key driver for the growth of the pharmaceutical continuous manufacturing market.
What Segments Are Identified Within The Structure Of The Pharmaceutical Continuous Manufacturing Market?
The pharmaceutical continuous manufacturing market covered in this report is segmented –
1) By Product: Integrated Continuous System, Control And Software, Semi-Continuous System
2) By Therapeutics Type: Large Molecule, Small Molecule
3) By Formulation: Solid Formation, Liquid And Semi-Solid Formation
4) By Application: Final Drug Product Manufacturing, Active Pharmaceutical Ingredient (API) Manufacturing
5) By End-Users: Pharmaceutical Companies, Contract Manufacturing Organization, Other End-Users
Subsegments:
1) By Integrated Continuous System: Continuous Mixer Systems, Continuous Granulation Systems, Continuous Tablet Press Systems, Continuous Coating Systems
2) By Control and Software: Process Analytical Technology (PAT) Tools, Manufacturing Execution Systems (MES), Control Software for Automation, Data Management and Visualization Software
3) By Semi-Continuous System: Batch-to-Continuous Transition Systems, Hybrid Systems, Semi-Continuous Granulation and Drying Systems
What Trends Are Driving The Growth Trajectory Of The Pharmaceutical Continuous Manufacturing Market?
Leading firms within the pharmaceutical continuous manufacturing market are prioritizing the creation of sophisticated equipment, including continuous manufacturing lines, to achieve a competitive advantage. A Continuous Manufacturing (CM) line represents a specialized production method where raw materials are smoothly processed into final products without any halts or breaks. As an illustration, in January 2023, WuXi STA, a contract research, development, and manufacturing organization (CRDMO) based in China, introduced its Continuous Manufacturing (CM) line specifically for oral solids in Wuxi City, China. This CM line adheres to global cGMP standards and advances oral drug development through the integration of continuous direct compression equipment for tasks like dispensing, blending, lubrication, tablet compression, and coating. Significantly, Process Analytical Technology (PAT) is incorporated to continuously monitor blending uniformity, thereby guaranteeing superior product quality.
Which Major Industry Participants Are Leading The Pharmaceutical Continuous Manufacturing Market Growth?
Major companies operating in the pharmaceutical continuous manufacturing market are Pfizer Inc., Robert Bosch GmbH, Siemens AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline Plc., Eli Lilly and Company, Corning Inc., Vertex Pharmaceuticals, Lonza Group Ltd., GEA Group AG, Catalent Inc., Mettler Toledo, Patheon, Cytiva, Samsung Biologics Co.Ltd., WuXi Biologics, Syntegon Technology GmbH, Coperion GmbH, Hosokawa Micron Group, FUJIFILM Diosynth Biotechnologies, Leistritz AG, Glatt GmbH, Freund-Vector Corp., SK biotek Co. Ltd., Gericke AG, GEBRÜDER LÖDIGE MASCHINENBAU GmbH, Munson Machinery Company Inc., L.B. Bohle Maschinen und Verfahren GmbH, KORSCH AG, Chemtrix BV
Access The Complete Report For Deeper Market Insights:
Which Region Is Expected To Experience The Fastest Growth In The Pharmaceutical Continuous Manufacturing Market?
Western Europe was the largest region in the pharmaceutical continuous manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical continuous manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Pharmaceutical Continuous Manufacturing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12123&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Continuous Manufacturing Market 2026, By The Business Research Company
Pharmaceutical Continuous Manufacturing Market Report 2026
Fill Finish Pharmaceutical Contract Manufacturing Market Report 2026
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
